What have we learnt from community-acquired infections in Hong Kong?

被引:8
|
作者
Ling, JM [1 ]
Lam, AW [1 ]
Chan, EW [1 ]
Cheng, AE [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Microbiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
关键词
community-acquired infections; antimicrobial susceptibilities;
D O I
10.1093/jac/dkg167
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was initiated throughout Hong Kong, to reveal the characteristics of community-acquired infections. All specimens collected by general practitioners from infected patients were followed prospectively, and those that were culture-positive were analysed. Four thousand seven hundred and forty-one specimens were collected from 3977 patients by 89 doctors from July 2000 to October 2001. The most common specimens were throat swabs (33%), urine (26%) and sputa (16%). The average culture-positive rate was 28%. The most common organisms were Escherichia coli (18%), beta-haemolytic streptococci (15%) and Staphylococcus aureus (12%). Fluoroquinolone resistance was relatively high (up to 35%) in organisms commonly causing urinary tract infection (E. coli, Proteus and Morganella). Although none of the pneumococci was resistant to penicillin 1 mg/L, the proportion with intermediate resistance (0.1-1 mg/L) was alarming (81%). There were three strains of methicillin-resistant S. aureus. A decrease in ampicillin resistance but a high prevalence of macrolide resistance were noted in Haemophilus influenzae. All Neisseria gonorrhoeae isolates were resistant to penicillin, up to 79% to the fluoroquinolones, 15% to spectinomycin, but all were susceptible to ceftriaxone. Respiratory pathogens (Streptococcus pneumoniae, P-haemolytic streptococci and H. influenzae) were relatively susceptible to the newer fluoroquinolones (0-2%, 0.5-6% and 2% resistant, respectively) or third-generation cephalosporins (0-2% resistant). The distribution of organisms and their antibiotic resistance varied over time. Thus frequent surveillance is needed to provide information on the drugs of choice for different infections.
引用
收藏
页码:895 / 904
页数:10
相关论文
共 50 条
  • [21] What Have We Learnt? A year on from the first UK Community Partner Summit
    Aumann, Kim
    Hart, Angie
    Duncan, Sophie
    [J]. GATEWAYS-INTERNATIONAL JOURNAL OF COMMUNITY RESEARCH AND ENGAGEMENT, 2014, 7 (01): : 129 - 143
  • [22] What have we learnt from the convergence debate?
    Islam, N
    [J]. JOURNAL OF ECONOMIC SURVEYS, 2003, 17 (03) : 309 - 362
  • [23] What have we learnt from the rosiglitazone saga?
    Montori, Victor M.
    Shah, Nilay D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [24] What we should have learnt from Mandela
    Chasi, Colin
    [J]. AFRICAN STUDIES, 2017, 76 (04) : 491 - 507
  • [25] What have we learnt from triggering migraine?
    Schytz, Henrik W.
    Schoonman, Guus G.
    Ashina, Messoud
    [J]. CURRENT OPINION IN NEUROLOGY, 2010, 23 (03) : 259 - 265
  • [26] What have we learnt from palaeoclimate simulations?
    Harrison, Sandy P.
    Bartlein, Patrick J.
    Prentice, I. Colin
    [J]. JOURNAL OF QUATERNARY SCIENCE, 2016, 31 (04) : 363 - 385
  • [27] Community-acquired Acinetobacter infections
    M. E. Falagas
    E. A. Karveli
    I. Kelesidis
    T. Kelesidis
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 857 - 868
  • [28] COMMUNITY-ACQUIRED INFECTIONS IN 1993
    LUCHT, F
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 (01): : 19 - 20
  • [29] Community-acquired Acinetobacter infections
    Falagas, M. E.
    Karveli, E. A.
    Kelesidis, I.
    Kelesidis, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (12) : 857 - 868
  • [30] What have we really learnt?
    Tremblay, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337